Skip to main content

Table 1 Characteristics of the subjects in the Saguenay_Lac-Saint-Jean study.

From: Asthma and genes encoding components of the vitamin D pathway

 

All subjects

(n = 1064)

Probands

(n = 210)

Affected members

(n = 320)

Unaffected members

(n = 534)

Age (years)

39.7 ± 22.1

17.6 ± 9.4

40.0 ± 19.5

48.3 ± 21.1

Male: Female ratio

0.80

0.86

0.68

0.85

Mean age of onset (years)

16.5 ± 17.0

7.4 ± 7.6

22.3 ± 18.7

NA

FEV1 (% predicted)

94.1 ± 19.8

92.5 ± 16.1

88.9 ± 23.2

99.1 ± 17.2

PEFR (%)

6.4 ± 4.6

7.3 ± 4.2

7.4 ± 5.9

5.0 ± 2.9

PC20 (mg/ml)

21.1 ± 24.9

5.1 ± 8.5

8.8 ± 15.4

39.4 ± 24.9

Serum IgE (mg/L)

452.7 ± 1619.2

720.3 ± 1919.9

531.4 ± 1960.8

244.8 ± 1005.9

Atopy (n)

593 (56.3%)

171 (81.8%)

218 (69.2%)

204 (38.6%)

Smoking Status (n)

    

Never

551 (52.6%)

173 (84.0%)

154 (48.7%)

224 (42.7%)

Ex-smoker

291 (27.8%)

11 (5.3%)

100 (31.7%)

180 (34.3%)

Smoker

205 (19.6%)

22 (10.7%)

62 (19.6%)

121 (23.1%)

  1. Values are means ± SD for quantitative variables.
  2. FEV1, Forced expiratory volume in one second; PC20, Concentration of methacholine inducing a 20% fall in FEV1; PEFR, Peak expiratory flow rate (morning-evening variation).